| Phase 2 |
| NCT06241781 |
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or… |
Adult |
Recruiting |
| Phase 1/2 |
| NCT06948981 |
GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell… |
Hematological Malignancy (Leukemia- Lymphoma) |
Recruiting |
| NCT06144671 |
GT201 Injection For The Treatment Of Advanced Solid Tumors |
Solid Tumor, Adult |
Recruiting |
| Phase 1 |
| NCT07021209 |
GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases |
Neurological Autoimmune Diseases |
Recruiting |
| NCT06088472 |
TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors |
Solid Tumors, Adult |
Recruiting |
| NCT05430373 |
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors |
Solid Tumors, Adult |
Recruiting |
| NCT06819293 |
IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma |
Advanced Clear Renal Cell Carcinoma |
Recruiting |
| Early Phase 1 |
| NCT07122076 |
GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases |
Autoimmune Diseases |
Recruiting |
| NCT07131254 |
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in… |
Hematological Malignancy (Leukemia- Lymphoma) |
Recruiting |
| NCT07253259 |
A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in… |
cGVHD |
Recruiting |
| NCT07132112 |
GT719 Injection for Moderate to Severe Refractory Autoimmune Disease |
Auto Immune Disease |
Recruiting |
| NCT07333118 |
A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment… |
Moderate to Severe Refractory Autoimmune Disease |
Recruiting |
| NCT07205315 |
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients… |
B-cell Acute Lymphoblastic Leukemia (B-ALL) |
Recruiting |
| NCT07389499 |
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in… |
IgA Nephropathy (IgAN) |
Not Yet Recruiting |
| NCT07676006 |
A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell… |
Relapsed/Refractory Acute Myeloid Leukemia (AML) |
Not Yet Recruiting |
| Not specified |
| NCT06397963 |
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients… |
Solid Tumor, Adult |
Recruiting |
| NCT06453057 |
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid… |
Adult |
Recruiting |
| NCT06819280 |
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced… |
Adult |
Recruiting |
| NCT06190275 |
Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck… |
HNSCC |
Recruiting |